National Research Corporation logo

National Research Corporation (NRC)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
20. 44
-0.5
-2.3878%
After Hours
$
23. 50
+3.06 +14.9706%
492.43M Market Cap
33.66 P/E Ratio
0.64% Div Yield
71,381 Volume
0 Eps
$ 20.94
Previous Close
Add Transaction
Day Range
20.43 21.22
Year Range
11.01 23.68
Want to track NRC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

National Research Corporation (NRC) Statistics

Valuation metrics

Market Cap 492.43M
Enterprise value 579.13M
Trailing P/E (ttm) 83.24
Forward P/E 14.81
PEG ratio -1.26
Price/Sales (ttm) 3.52
Price/Book (mrq) 73.43
Enterprise Value/Revenue 4.14
Enterprise Value/EBITDA 24.73

Overview

Shares outstanding 22.64M
Float 12.19M
Shares short 435.24K
% Held by insiders 0.48%
% Held by institutions 0.48%
Average volume (10 days) 84.32K
Average volume (90 days) 95.33K

Price summary

52-Week low 11.01
52-Week high 23.68
Beta 0.41
50-Day moving average 21.14
200-Day moving average 17.56

Dividends and splits

Forward annual dividend rate 0.64
Forward annual dividend yield 0.0366%
Trailing annual dividend rate 0.6
Trailing annual dividend yield 0.0275%
5-Year annual dividend yield 1.97%
Payout ratio 2.17
Dividend Date 10 Jul 2026
Ex-Dividend Date 26 Jun 2026
Last split factor -
Last split Date -

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin 0.04%
Operating margin 0.11%

Operational effectiveness

Return on assets 0.04%
Return on equity 0.48%

Income Statement

Revenue (ttm) 137.39M
Revenue per share (ttm) 6.36
Quarterly revenue growth (yoy) -0.05%
Gross profit (ttm) 85.02M
EBITDA 30.23M
Net income to common (ttm) 11.29M
Diluted EPS (ttm) 0.27
Quarterly earnings growth (yoy) -0.73%

Balance Sheet

Total cash (mrq) 4.14M
Total cash per share (mrq) 0.15
Total debt (mrq) 80.24M
Total Debt/Equity (mrq) 13.75
Current ratio (mrq) 0.65%
Book value per share (mrq) 0.3

Cash Flow

Cash flow statement 26.45M
Levered free cash flow (LFCF) 16.65M